Dr. David Ewing, MD
NPI: 1083054100
Total Payments
$731.23
2024 Payments
$41.04
Companies
9
Transactions
37
Medicare Patients
5,958
Medicare Billing
$394,391
Payment Breakdown by Category
Food & Beverage$731.23 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $731.23 | 37 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lundbeck LLC | $331.55 | 20 | $0 (2024) |
| SK Life Science, Inc. | $159.06 | 8 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $123.70 | 1 | $0 (2018) |
| Xeris Pharmaceuticals, Inc. | $44.31 | 3 | $0 (2021) |
| Neurocrine Biosciences, Inc. | $21.74 | 1 | $0 (2022) |
| JAZZ PHARMACEUTICALS INC. | $14.23 | 1 | $0 (2021) |
| Lilly USA, LLC | $12.97 | 1 | $0 (2023) |
| Allergan Inc. | $12.78 | 1 | $0 (2017) |
| GENZYME CORPORATION | $10.89 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $41.04 | 2 | Lundbeck LLC ($41.04) |
| 2023 | $73.71 | 4 | Lundbeck LLC ($60.74) |
| 2022 | $137.85 | 7 | SK Life Science, Inc. ($62.84) |
| 2021 | $176.74 | 11 | SK Life Science, Inc. ($74.70) |
| 2020 | $59.64 | 3 | Lundbeck LLC ($38.12) |
| 2019 | $39.31 | 3 | Lundbeck LLC ($28.42) |
| 2018 | $145.66 | 3 | AstraZeneca Pharmaceuticals LP ($123.70) |
| 2017 | $57.28 | 4 | Lundbeck LLC ($44.50) |
All Payment Transactions
37 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/08/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $19.46 | General |
| Category: NEUROLOGY | ||||||
| 03/15/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $21.58 | General |
| Category: NEUROLOGY | ||||||
| 09/11/2023 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $18.39 | General |
| Category: PSYCHIATRY | ||||||
| 04/29/2023 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $21.09 | General |
| Category: NEUROLOGY | ||||||
| 04/29/2023 | Lilly USA, LLC | EMGALITY (Drug), REYVOW | Food and Beverage | In-kind items and services | $12.97 | General |
| Category: Neuroscience | ||||||
| 02/04/2023 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $21.26 | General |
| Category: NEUROLOGY | ||||||
| 09/08/2022 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $31.95 | General |
| 08/25/2022 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $25.92 | General |
| Category: NEUROLOGY | ||||||
| 06/09/2022 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $18.74 | General |
| 05/03/2022 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $15.51 | General |
| Category: NEUROLOGY | ||||||
| 04/18/2022 | Neurocrine Biosciences, Inc. | Ongentys (Drug), INGREZZA | Food and Beverage | In-kind items and services | $21.74 | General |
| Category: Neuropsychiatry | ||||||
| 03/12/2022 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $12.15 | General |
| 01/18/2022 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $11.84 | General |
| Category: NEUROLOGY | ||||||
| 12/15/2021 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $21.70 | General |
| 09/22/2021 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $21.73 | General |
| 08/12/2021 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $14.23 | General |
| Category: NEUROLOGY | ||||||
| 08/09/2021 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $13.20 | General |
| Category: NEUROLOGY | ||||||
| 04/26/2021 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $11.50 | General |
| Category: NEUROLOGY | ||||||
| 03/16/2021 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $16.22 | General |
| 02/23/2021 | Xeris Pharmaceuticals, Inc. | KEVEYIS (Drug) | Food and Beverage | In-kind items and services | $15.62 | General |
| Category: CARBONIC ANHYDRASE INHIBITOR | ||||||
| 02/01/2021 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $18.80 | General |
| Category: NEUROLOGY | ||||||
| 01/27/2021 | Xeris Pharmaceuticals, Inc. | KEVEYIS (Drug) | Food and Beverage | In-kind items and services | $15.88 | General |
| Category: CARBONIC ANHYDRASE INHIBITOR | ||||||
| 01/21/2021 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $15.05 | General |
| 01/11/2021 | Xeris Pharmaceuticals, Inc. | KEVEYIS (Drug) | Food and Beverage | In-kind items and services | $12.81 | General |
| Category: CARBONIC ANHYDRASE INHIBITOR | ||||||
| 09/17/2020 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $21.52 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 2,124 | 3,522 | $843,399 | $186,550 |
| 2022 | 13 | 1,129 | 2,001 | $332,932 | $58,851 |
| 2021 | 14 | 1,437 | 2,553 | $478,225 | $81,273 |
| 2020 | 13 | 1,268 | 2,122 | $382,287 | $67,716 |
Total Patients
5,958
Total Services
10,198
Medicare Billing
$394,391
Procedure Codes
57
All Medicare Procedures & Services
57 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0416 | Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method | Office | 2023 | 448 | 567 | $449,723 | $76,950 | 17.1% |
| 88344 | Special stained specimen slides to examine tissue, each multiplex procedure | Office | 2023 | 157 | 594 | $97,405 | $42,627 | 43.8% |
| 88112 | Cell examination of specimen, selective cellular enhancement technique | Office | 2023 | 839 | 1,061 | $107,205 | $30,213 | 28.2% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Facility | 2023 | 241 | 433 | $68,310 | $12,200 | 17.9% |
| 88307 | Pathology examination of tissue using a microscope, moderately high complexity | Facility | 2023 | 83 | 114 | $41,537 | $7,154 | 17.2% |
| 88341 | Special stained specimen slides to examine tissue, each additional procedure | Facility | 2023 | 67 | 291 | $30,870 | $6,220 | 20.1% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Facility | 2023 | 126 | 143 | $15,285 | $3,838 | 25.1% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2023 | 35 | 104 | $15,510 | $3,233 | 20.8% |
| 88360 | Microscopic genetic analysis of tumor, manual | Facility | 2023 | 26 | 47 | $4,813 | $1,489 | 30.9% |
| 88331 | Pathology examination of specimen during surgery, first tissue block | Facility | 2023 | 14 | 20 | $3,099 | $971.91 | 31.4% |
| 88313 | Special stained specimen slides to examine tissue including interpretation and report | Facility | 2023 | 21 | 68 | $2,432 | $586.02 | 24.1% |
| 88312 | Special stained specimen slides to identify organisms including interpretation and report | Facility | 2023 | 14 | 19 | $2,206 | $448.42 | 20.3% |
| 88304 | Pathology examination of tissue using a microscope, moderately low complexity | Facility | 2023 | 37 | 42 | $4,395 | $427.73 | 9.7% |
| 88311 | Preparation of tissue for examination by removing any calcium present | Facility | 2023 | 16 | 19 | $610.00 | $191.43 | 31.4% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Facility | 2022 | 337 | 574 | $116,197 | $16,097 | 13.9% |
| 88307 | Pathology examination of tissue using a microscope, moderately high complexity | Facility | 2022 | 146 | 201 | $64,786 | $12,614 | 19.5% |
| 88341 | Special stained specimen slides to examine tissue, each additional procedure | Facility | 2022 | 104 | 331 | $34,641 | $7,316 | 21.1% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2022 | 73 | 199 | $30,990 | $6,280 | 20.3% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Facility | 2022 | 152 | 176 | $20,870 | $4,858 | 23.3% |
| 88360 | Microscopic genetic analysis of tumor, manual | Facility | 2022 | 37 | 88 | $15,680 | $2,892 | 18.4% |
| 88331 | Pathology examination of specimen during surgery, first tissue block | Facility | 2022 | 34 | 47 | $8,856 | $2,304 | 26.0% |
| 88309 | Pathology examination of tissue using a microscope, high complexity | Facility | 2022 | 19 | 19 | $7,994 | $2,173 | 27.2% |
| 88313 | Special stained specimen slides to examine tissue including interpretation and report | Facility | 2022 | 50 | 172 | $13,502 | $1,456 | 10.8% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Office | 2022 | 14 | 17 | $3,090 | $964.50 | 31.2% |
| 88304 | Pathology examination of tissue using a microscope, moderately low complexity | Facility | 2022 | 88 | 93 | $9,653 | $792.15 | 8.2% |
About Dr. David Ewing, MD
Dr. David Ewing, MD is a Anatomic Pathology & Clinical Pathology healthcare provider based in North Kansas City, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/03/2013. The National Provider Identifier (NPI) number assigned to this provider is 1083054100.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Ewing, MD has received a total of $731.23 in payments from pharmaceutical and medical device companies, with $41.04 received in 2024. These payments were reported across 37 transactions from 9 companies. The most common payment nature is "Food and Beverage" ($731.23).
As a Medicare-enrolled provider, Ewing has provided services to 5,958 Medicare beneficiaries, totaling 10,198 services with total Medicare billing of $394,391. Data is available for 4 years (2020–2023), covering 57 distinct procedure/service records.
Ad
Practice Information
- Specialty Anatomic Pathology & Clinical Pathology
- Location North Kansas City, MO
- Active Since 07/03/2013
- Last Updated 07/24/2018
- Taxonomy Code 207ZP0102X
- Entity Type Individual
- NPI Number 1083054100
Products in Payments
- VYEPTI (Biological) $218.28
- NORTHERA (Drug) $51.04
- KEVEYIS (Drug) $44.31
- ONFI (Drug) $43.84
- Ongentys (Drug) $21.74
- REXULTI (Drug) $18.39
- XYWAV (Drug) $14.23
- EMGALITY (Drug) $12.97
- NAMZARIC (Drug) $12.78
- AUBAGIO (Drug) $10.89
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.